EVE Health Group Limited Cash Flow Conversion Efficiency
EVE Health Group Limited cash flow conversion efficiency. Based on the latest financial reports, EVE Health Group Limited (EVE) has a cash flow conversion efficiency ratio of -0.242x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-907.94K ≈ $-642.42K USD) by net assets (AU$3.76 Million ≈ $2.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of EVE Health Group Limited (2004–2025)
Cash flow conversion efficiency of EVE Health Group Limited from 2004 to 2025. This chart illustrates how EVE Health Group Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View EVE stock price and chart for real-time trading data and today's change.
EVE Health Group Limited Cash Flow Conversion Ratio Explained
EVE Health Group Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
EVE Health Group Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EVE Health Group Limited ranked by their cash flow conversion efficiency. Also see EVE company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fidelity Japanese Values PLC ORD
LSE:FJV
|
-0.002x |
|
Remsense Technologies Ltd
AU:REM
|
0.009x |
|
Springs Global Participações S.A.
SA:SGPS3
|
0.044x |
|
Jaya Swarasa Agung PT
JK:TAYS
|
0.001x |
|
Omnia Metals Group Ltd
AU:OM1
|
-0.055x |
|
Magnetic North Acquisition Corp
V:MNC
|
0.115x |
|
METALQUEST MINING INC.
F:E7Q
|
-0.031x |
|
Kingsland Minerals Ltd
AU:KNG
|
-0.081x |
Annual Cash Flow Conversion Efficiency for EVE Health Group Limited (2004–2025)
The table below shows the annual cash flow conversion efficiency of EVE Health Group Limited from 2004 to 2025. Review EVE FCF to total liabilities ratio to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$3.55 Million ≈ $2.51 Million |
AU$-1.62 Million ≈ $-1.14 Million |
-0.455x | +49.72% |
| 2024-06-30 | AU$1.22 Million ≈ $866.05K |
AU$-1.11 Million ≈ $-783.25K |
-0.904x | -71.38% |
| 2023-06-30 | AU$3.12 Million ≈ $2.21 Million |
AU$-1.65 Million ≈ $-1.17 Million |
-0.528x | +3.00% |
| 2022-06-30 | AU$6.93 Million ≈ $4.91 Million |
AU$-3.77 Million ≈ $-2.67 Million |
-0.544x | -146.98% |
| 2021-06-30 | AU$10.19 Million ≈ $7.21 Million |
AU$-2.24 Million ≈ $-1.59 Million |
-0.220x | +9.31% |
| 2020-06-30 | AU$12.99 Million ≈ $9.19 Million |
AU$-3.16 Million ≈ $-2.23 Million |
-0.243x | -32.63% |
| 2019-06-30 | AU$5.85 Million ≈ $4.14 Million |
AU$-1.07 Million ≈ $-757.90K |
-0.183x | -67.12% |
| 2018-06-30 | AU$7.38 Million ≈ $5.22 Million |
AU$-808.76K ≈ $-572.25K |
-0.110x | +45.55% |
| 2017-06-30 | AU$2.78 Million ≈ $1.97 Million |
AU$-558.99K ≈ $-395.52K |
-0.201x | +45.42% |
| 2016-06-30 | AU$1.75 Million ≈ $1.24 Million |
AU$-645.76K ≈ $-456.92K |
-0.369x | -305.44% |
| 2015-06-30 | AU$2.64 Million ≈ $1.87 Million |
AU$-240.46K ≈ $-170.14K |
-0.091x | -368.93% |
| 2014-06-30 | AU$8.11 Million ≈ $5.74 Million |
AU$-157.19K ≈ $-111.23K |
-0.019x | +79.66% |
| 2013-06-30 | AU$8.18 Million ≈ $5.79 Million |
AU$-779.82K ≈ $-551.77K |
-0.095x | -39.15% |
| 2012-06-30 | AU$23.04 Million ≈ $16.30 Million |
AU$-1.58 Million ≈ $-1.12 Million |
-0.069x | +64.89% |
| 2011-06-30 | AU$25.64 Million ≈ $18.14 Million |
AU$-5.00 Million ≈ $-3.54 Million |
-0.195x | -117.47% |
| 2010-06-30 | AU$25.15 Million ≈ $17.79 Million |
AU$-2.26 Million ≈ $-1.60 Million |
-0.090x | +29.17% |
| 2009-06-30 | AU$22.93 Million ≈ $16.23 Million |
AU$-2.91 Million ≈ $-2.06 Million |
-0.127x | -29.01% |
| 2008-06-30 | AU$25.64 Million ≈ $18.14 Million |
AU$-2.52 Million ≈ $-1.78 Million |
-0.098x | -34.67% |
| 2007-06-30 | AU$18.78 Million ≈ $13.29 Million |
AU$-1.37 Million ≈ $-969.08K |
-0.073x | -104.92% |
| 2006-06-30 | AU$5.98 Million ≈ $4.23 Million |
AU$-212.78K ≈ $-150.56K |
-0.036x | +46.18% |
| 2005-06-30 | AU$2.22 Million ≈ $1.57 Million |
AU$-146.87K ≈ $-103.92K |
-0.066x | +70.17% |
| 2004-06-30 | AU$251.35K ≈ $177.84K |
AU$-55.71K ≈ $-39.42K |
-0.222x | -- |
About EVE Health Group Limited
EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erect… Read more